Patient Care

Inpatient Consultative Services

The Division of Infectious Diseases has very active inpatient consultative services, with well-balanced exposure to different infectious diseases problems at three major locations:

  • Memorial Herman Hospital-TMC
    A full service private hospital specializing in trauma care with active CV surgery and solid organ transplant programs, a burn unit, and the tertiary referral hospital for over 10 outlying regional Memorial Hermann hospitals.
  • Lyndon Baines Johnson Hospital
    Part of the Harris Health System, a hospital serving lower resource patients.
  • Infectious diseases fellows also see patients at the UT M.D. Anderson Cancer Center, a world renowned patient care and research center featuring training on leukemia, solid tumor, bone marrow transplant and ICU services.

Outpatient Consultative Services

The Division of Infectious Diseases sees outpatients with the full range of infectious diseases, including HIV/AIDS, osteomyelitis, chronic fatigue, Lyme, and tropical diseases acquired during travel. The Division also staffs a full service travel medicine clinic that prepares clients to travel safely to exotic locations. Services include medications to prevent malaria and treat travelers’ diarrhea and all the necessary immunizations for travel. The staff takes pride in spending the time to individualize the needs of the traveler and educate them accordingly. Fellows also rotate one morning a week in an HIV continuity clinic.

  • UT Physicians ID Clinics (TMC and Bellaire sites)
    Continuity clinics serving a wide range of ID consultations, including Transplant ID and fungal diseases.
  • Bellaire Travel Medicine Clinic
    Full-service clinic preparing clients for safe travel to exotic locations
  • Quentin Mease Health Center
    Continuity clinic of Harris Health System serving low resource patients with HIV infection (+/- HCV infections)
  • Infectious diseases fellows also see patients at MDACC HCV and Cancer ID clinics.
    These clinics serve HCV positive immunocompromised hosts and patients with cancer with infectious diseases problems.